Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) Stock Price

ELOXStock

$19.29−78.70%52W

Market Cap$66.29M

P/E—

PEG Ratio1.85

Div yield—

Beta3.28

ELOX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-87.99%

Price vs S&P 500 (4W)53.00%

PEG Ratio1.85

VGM Score53.41

Book Value / Share (Quarterly)$0.84

P/TBV (Annual)6.47x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)329.96%

Cash Flow / Share (Quarterly)$-1.31

Price vs S&P 500 (YTD)-46.26%

Net Profit Margin (TTM)-3862.50%

EPS (TTM)$-7.06

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$-7.06

EPS (Annual)$-0.49

ROI (Annual)-194.09%

Net Profit Margin (5Y Avg)-8945.39%

Cash / Share (Quarterly)$1.25

ROA (Last FY)-113.76%

EBITD / Share (TTM)$-0.08

ROE (5Y Avg)-197.18%

Operating Margin (TTM)-4412.50%

Cash Flow / Share (Annual)$-1.32

P/B Ratio0.44x

P/B Ratio (Quarterly)12.91x

Net Income / Employee (Annual)$-599,500

EV / Revenue (TTM)-34.79x

Net Interest Coverage (TTM)-5.51x

ROA (TTM)-44.15%

EPS Incl Extra (Annual)$-0.49

Current Ratio (Annual)0.31x

Quick Ratio (Quarterly)0.45x

3-Month Avg Trading Volume0.04M

52-Week Price Return-78.70%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$2.66

P/S Ratio (Annual)0.13x

Asset Turnover (Annual)2.14x

52-Week High$23.40

Operating Margin (5Y Avg)-9696.34%

EPS Excl Extra (Annual)$-0.49

Tangible BV CAGR (5Y)-6.55%

26-Week Price Return-87.06%

Quick Ratio (Annual)0.28x

13-Week Price Return3534.55%

Total Debt / Equity (Annual)0.54x

Current Ratio (Quarterly)0.53x

Enterprise Value$-5.57M

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)76.53%

Revenue / Employee (Annual)$635,900

Pretax Margin (Annual)-49.43%

Cash / Share (Annual)$1.00

3-Month Return Std Dev2261.65%

Net Income / Employee (TTM)$-375,400

ROE (Last FY)-298.10%

Net Interest Coverage (Annual)-624.67x

EPS Basic Excl Extra (Annual)$-0.49

Receivables Turnover (TTM)4.00x

Total Debt / Equity (Quarterly)6.76x

EPS Incl Extra (TTM)$-7.06

ROI (TTM)-150.95%

P/S Ratio (TTM)4.98x

Pretax Margin (5Y Avg)-9115.39%

Revenue / Share (Annual)$1.69

Tangible BV / Share (Annual)$2.59

Price vs S&P 500 (52W)-81.38%

Year-to-Date Return-36.81%

5-Day Price Return9.53%

EPS Normalized (Annual)$-0.49

ROA (5Y Avg)-306.82%

Net Profit Margin (Annual)-49.43%

Month-to-Date Return14.69%

Cash Flow / Share (TTM)$-8.79

EBITD / Share (Annual)$-0.41

Operating Margin (Annual)-39.20%

LT Debt / Equity (Annual)0.54x

ROI (5Y Avg)-132.25%

LT Debt / Equity (Quarterly)6.14x

EPS Basic Excl Extra (TTM)$-7.06

P/TBV (Quarterly)4.44x

P/B Ratio (Annual)2.72x

Pretax Margin (TTM)-3862.50%

Book Value / Share (Annual)$10.33

Price vs S&P 500 (13W)3531.75%

Beta3.28x

Revenue / Share (TTM)$0.00

ROE (TTM)-256.75%

52-Week Low$0.00

mGradeC

vgmGradeC

ELOX Earnings Surprise History

Q4 22-33.55est. -32.67

Q1 23-31.68est. -28.05

Q2 23-21.56est. -16.94

Q3 23-14.41est. -21.67

ELOX Analyst Recommendations

Jul 2024

Aug 2024

Sep 2024

Aug 2026

4.29

4.14

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
ELOXEloxx Pharmaceuticals, Inc. Common Stock	—	—	C	$19.29
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About Eloxx Pharmaceuticals, Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.